Overcoming Prostate Cancer Disparities in Care

The COVID-19 pandemic has resulted in a devastating plunge in the number of cancer screenings in the U.S. during the past year. A new report anticipates a 30 percent rise in newly diagnosed cases of prostate cancer in 2021, due in part to men deferring their annual checkups because of the pandemic. This means that nearly 250,000 men will be diagnosed with prostate cancer in 2021, and more than 34,100 men will die as a result. Leading physicians and researchers say 2022 numbers could be even higher.

The report also found that the incidence of prostate cancer is almost 80 percent higher in non-Hispanic Black men than in non-Hispanic White men, and the death rate for Black men with prostate cancer is more than double that of men in every other group. There are multiple reasons for this disparity. Since prostate cancer is slow to develop, if it is caught early and actively monitored, men are more likely to have positive outcomes. However, for men who do not have regular and equal access to the healthcare system, it is less likely that their cancers will be detected at an early, more manageable stage.

This project will join other ACCC initiatives that are addressing inequities in cancer care, including increasing the representation of underserved populations in cancer clinical trials and eliminating disparities in access to precision medicine. ACCC will recruit from its membership four practices of varying resource levels, each of which will share its work overcoming a specific disparity in care for their patients with prostate cancer. The practice profiles created by this project will be used to provide similar cancer programs a practical model for tackling disparities in care.

For more information on this project, please contact the ACCC Provider Education department.